Michael Cannon-Brookes Sells 7,665 Shares of Atlassian (NASDAQ:TEAM) Stock

Atlassian Corporation PLC (NASDAQ:TEAMGet Free Report) CEO Michael Cannon-Brookes sold 7,665 shares of the firm’s stock in a transaction on Friday, November 7th. The stock was sold at an average price of $155.58, for a total transaction of $1,192,520.70. Following the completion of the sale, the chief executive officer owned 275,940 shares in the company, valued at $42,930,745.20. This represents a 2.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Michael Cannon-Brookes also recently made the following trade(s):

  • On Wednesday, November 5th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $162.66, for a total transaction of $1,246,788.90.
  • On Monday, November 3rd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $172.78, for a total transaction of $1,324,358.70.
  • On Friday, October 31st, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $167.61, for a total transaction of $1,284,730.65.
  • On Wednesday, October 29th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $160.40, for a total value of $1,229,466.00.
  • On Monday, October 27th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $165.03, for a total value of $1,264,954.95.
  • On Friday, October 24th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $164.50, for a total transaction of $1,260,892.50.
  • On Wednesday, October 22nd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $169.16, for a total value of $1,296,611.40.
  • On Friday, October 17th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $151.21, for a total value of $1,159,024.65.
  • On Monday, October 20th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $157.28, for a total value of $1,205,551.20.
  • On Wednesday, October 15th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $151.83, for a total value of $1,163,776.95.

Atlassian Price Performance

Shares of NASDAQ TEAM traded up $1.30 during trading on Monday, reaching $159.13. The company had a trading volume of 2,392,267 shares, compared to its average volume of 2,500,841. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.26 and a current ratio of 1.26. Atlassian Corporation PLC has a 52 week low of $144.32 and a 52 week high of $326.00. The stock has a market cap of $41.87 billion, a PE ratio of -224.12, a PEG ratio of 37.43 and a beta of 0.95. The business’s 50 day moving average price is $163.23 and its 200-day moving average price is $186.41.

Atlassian (NASDAQ:TEAMGet Free Report) last posted its quarterly earnings results on Thursday, October 30th. The technology company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.21. The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.40 billion. Atlassian had a negative return on equity of 7.11% and a negative net margin of 3.38%.The firm’s quarterly revenue was up 20.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.77 earnings per share. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts expect that Atlassian Corporation PLC will post -0.34 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Cowen restated a “hold” rating on shares of Atlassian in a report on Monday, October 27th. Robert W. Baird set a $230.00 target price on shares of Atlassian in a research report on Friday, October 31st. Zacks Research upgraded Atlassian from a “strong sell” rating to a “hold” rating in a research report on Monday, November 3rd. Raymond James Financial lowered their price target on Atlassian from $300.00 to $250.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Finally, Guggenheim began coverage on shares of Atlassian in a research report on Thursday, September 11th. They issued a “buy” rating and a $225.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $239.44.

Get Our Latest Stock Report on Atlassian

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Capco Asset Management LLC acquired a new stake in shares of Atlassian during the second quarter worth $25,000. Physician Wealth Advisors Inc. increased its holdings in Atlassian by 60.4% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock worth $26,000 after purchasing an additional 61 shares in the last quarter. Atlantic Union Bankshares Corp raised its stake in shares of Atlassian by 19,900.0% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after purchasing an additional 199 shares during the period. Smithfield Trust Co raised its stake in shares of Atlassian by 90.7% in the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock valued at $34,000 after purchasing an additional 78 shares during the period. Finally, Geneos Wealth Management Inc. lifted its holdings in shares of Atlassian by 447.2% in the first quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after purchasing an additional 161 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

About Atlassian

(Get Free Report)

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.

Read More

Insider Buying and Selling by Quarter for Atlassian (NASDAQ:TEAM)

Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.